NCT04772027
Motor Parameters in Patients With Limb Girdle Muscular Dystrophy No drug interventions Not Available Not Available recruiting NCT05618080
Trial Readiness and Endpoint Assessment in LGMD R1 No drug interventions Not Available Not Available recruiting NCT03981289
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) No drug interventions Not Available Not Available active_not_recruiting NCT05906251
A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related) No drug interventions treatment 1 active_not_recruiting NCT01126697
Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies treatment 2 / 3 completed NCT02245711
Cell Therapy in Limb Girdle Muscular Dystrophy No drug interventions treatment 1 withdrawn NCT06390566
Evolution of the Functional and Muscular State of Patients With Muscular Dystrophy 2A Belts No drug interventions Not Available Not Available not_yet_recruiting NCT02050776
Stem Cell Therapy in Limb Girdle Muscular Dystrophy No drug interventions treatment 1 withdrawn NCT05876780
A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency) No drug interventions treatment 1 active_not_recruiting NCT01081080
Cardiac Magnetic Resonance in Children With Muscular Dystrophy No drug interventions Not Available Not Available completed NCT01066455
Cardiac Outcome Measures in Children With Muscular Dystrophy No drug interventions Not Available Not Available completed NCT06378203
Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI] No drug interventions treatment Not Available recruiting NCT05409079
Schulze Muscular Dystrophy Ability Clinical Study No drug interventions treatment Not Available recruiting NCT03930628
Limb-Girdle Muscular Dystrophy Type 2I in Norway No drug interventions Not Available Not Available active_not_recruiting NCT05230459
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) No drug interventions treatment 1 / 2 recruiting NCT05102799
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants No drug interventions Not Available Not Available recruiting NCT02836418
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 1 / 2 completed NCT05206617
3 Year Follow up on ANO5 Patients No drug interventions Not Available Not Available active_not_recruiting NCT04202627
Biomarker Development in LGMD2i No drug interventions Not Available Not Available completed NCT04001595
Global FKRP Registry No drug interventions Not Available Not Available recruiting NCT02579239
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 1 / 2 completed NCT02759302
MRI on Persons With Mutations in POMT2 Gene (LGMD2N) No drug interventions Not Available Not Available completed NCT01403402
Congenital Muscle Disease Study of Patient and Family Reported Medical Information No drug interventions Not Available Not Available recruiting NCT04054375
Weekly Steroids in Muscular Dystrophy treatment 2 completed NCT06399770
The Role of Muscle Ultrasound in Assessment of Sample of Patients With Limb-girdle Muscular Dystrophy No drug interventions Not Available Not Available not_yet_recruiting NCT06246513
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE) treatment 3 recruiting NCT00390104
Molecular Analysis of Patients With Neuromuscular Disease No drug interventions Not Available Not Available recruiting NCT03783923
A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I) treatment 3 terminated NCT02635321
MRI and Muscle Involvement in Patients With Mutations in GMPPB No drug interventions Not Available Not Available completed NCT00104078
Study Evaluating MYO-029 in Adult Muscular Dystrophy treatment 1 / 2 completed NCT04475926
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice No drug interventions Not Available Not Available recruiting NCT00873782
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy No drug interventions treatment 1 completed NCT00457912
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy No drug interventions Not Available Not Available completed